BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bruno G, Zaccari P, Rocco G, Scalese G, Panetta C, Porowska B, Pontone S, Severi C. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified. World J Gastroenterol 2019; 25(22): 2706-2719 [PMID: 31235994 DOI: 10.3748/wjg.v25.i22.2706]
URL: https://www.wjgnet.com/1007-9327/full/v25/i22/2706.htm
Number Citing Articles
1
Asimina Koulouridi, Ippokratis Messaritakis, Nikolaos Gouvas, John Tsiaoussis, John Souglakos. Immunotherapy in Solid Tumors and Gut Microbiota: The Correlation—A Special Reference to Colorectal CancerCancers 2020; 13(1): 43 doi: 10.3390/cancers13010043
2
Leon Fisher, Alexander Fisher, Paul N Smith. Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review)Journal of Clinical Medicine 2020; 9(10): 3253 doi: 10.3390/jcm9103253
3
Louis Gaucher, Leslie Adda, Alice Séjourné, Camille Joachim, Chaby Guillaume, Claire Poulet, Sophie Liabeuf, Valérie Gras-Champel, Kamel Masmoudi, Aline Houessinon, Youssef Bennis, Benjamin Batteux. Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitorsTherapeutic Advances in Medical Oncology 2021; 13: 175883592110005 doi: 10.1177/17588359211000591
4
Muhammad Miftahussurur, Boby Pratama Putra, Yoshio Yamaoka. The Potential Benefits of Vonoprazan as Helicobacter pylori Infection TherapyPharmaceuticals 2020; 13(10): 276 doi: 10.3390/ph13100276
5
Irene Gullo, Catarina Costa, Susana L. Silva, Cristina Ferreira, Adriana Motta, Sara P. Silva, Rúben Duarte Ferreira, Pedro Rosmaninho, Emília Faria, José Torres da Costa, Rita Câmara, Gilza Gonçalves, João Santos-Antunes, Carla Oliveira, José C. Machado, Fátima Carneiro, Ana E. Sousa. The Dysfunctional Immune System in Common Variable Immunodeficiency Increases the Susceptibility to Gastric CancerCells 2020; 9(6): 1498 doi: 10.3390/cells9061498
6
Zhi‐Hang Tao, Ji‐Xuan Han, Jing‐Yuan Fang. Helicobacter pylori infection and eradication: Exploring their impacts on the gastrointestinal microbiota Helicobacter 2020; 25(6) doi: 10.1111/hel.12754
7
Judith Wellens, João Sabino, Séverine Vermeire. PPIs and anti-TNF in patients with IBD: a forbidden combination?Gut 2021; : gutjnl-2021-324040 doi: 10.1136/gutjnl-2021-324040
8
Ana Almeida-Santos, Daniela Martins-Mendes, Magdalena Gayà-Vidal, Lucía Pérez-Pardal, Albano Beja-Pereira. Characterization of the Oral Microbiome of Medicated Type-2 Diabetes PatientsFrontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.610370
9
Claudio Barbiellini Amidei, Rosanna Comoretto, Loris Zanier, Daniele Donà, Anna Cantarutti, Cristina Canova. Acid-suppressive medications in the first year of life and risk of childhood asthma: a population-based birth cohort studyEuropean Respiratory Journal 2020; 56(5): 2000197 doi: 10.1183/13993003.00197-2020
10
Jong Min Park, Won Hee Lee, Hochan Seo, Ji Young Oh, Dong Yoon Lee, Seong Jin Kim, Ki Baik Hahm. Microbiota changes with fermented kimchi contributed to either the amelioration or rejuvenation of <i>Helicobacter pylori</i>-associated chronic atrophic gastritisJournal of Clinical Biochemistry and Nutrition 2021; 69(1): 98 doi: 10.3164/jcbn.20-123
11
Joshua Bilello, Ikenna Okereke. Impact of Environmental and Pharmacologic Changes on the Upper Gastrointestinal MicrobiomeBiomedicines 2021; 9(6): 617 doi: 10.3390/biomedicines9060617
12
Nele Brusselaers, Jesper Lagergren, Lars Engstrand. Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancerCancer Epidemiology 2019; 62: 101585 doi: 10.1016/j.canep.2019.101585
13
Volker Schirrmacher. Mitochondria at Work: New Insights into Regulation and Dysregulation of Cellular Energy Supply and MetabolismBiomedicines 2020; 8(11): 526 doi: 10.3390/biomedicines8110526
14
I. A. Krylova, V. I. Kupaev, A. V. Ljamin. Microbiological Characteristics of Intestinal Biocenosis of Ambulator Patients Having Behavioral Risk Factors for Chronic Non-Communicable DiseasesThe Russian Archives of Internal Medicine 2021; 11(3): 217 doi: 10.20514/2226-6704-2021-11-3-217-224
15
Thomas X Lu, Matthew Dapas, Erika Lin, Trevor Peters, Atsushi Sakuraba. The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controlled studiesGut 2021; 70(11): 2076 doi: 10.1136/gutjnl-2020-321609
16
Nadji Hannachi, Laurence Camoin-Jau. Drug Response Diversity: A Hidden Bacterium?Journal of Personalized Medicine 2021; 11(5): 345 doi: 10.3390/jpm11050345
17
Enrico Pierluigi Spugnini, Stefano Fais. Drug repurposing for anticancer therapies. A lesson from proton pump inhibitorsExpert Opinion on Therapeutic Patents 2020; 30(1): 15 doi: 10.1080/13543776.2020.1704733
18
M. Yadav, N.S. Chauhan. Overview of the rules of the microbial engagement in the gut microbiome: a step towards microbiome therapeuticsJournal of Applied Microbiology 2021; 130(5): 1425 doi: 10.1111/jam.14883
19
Luis A. García Rodríguez, Angel Lanas, Montse Soriano-Gabarró, Pareen Vora, Lucía Cea Soriano. Effect of Proton Pump Inhibitors on Risks of Upper and Lower Gastrointestinal Bleeding among Users of Low-Dose Aspirin: A Population-Based Observational StudyJournal of Clinical Medicine 2020; 9(4): 928 doi: 10.3390/jcm9040928
20
Issac E. Perry, Irene Sonu, Carmelo Scarpignato, Junichi Akiyama, Michio Hongo, Kenneth J. Vega. Potential proton pump inhibitor–related adverse effectsAnnals of the New York Academy of Sciences 2020; 1481(1): 43 doi: 10.1111/nyas.14428
21
Aleksandra Danielak, John L Wallace, Tomasz Brzozowski, Marcin Magierowski. Gaseous Mediators as a Key Molecular Targets for the Development of Gastrointestinal-Safe Anti-Inflammatory PharmacologyFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.657457
22
Hüseyin S Bozkurt, Ömer Bilen. Gastrointestinal symptoms in COVID-19 could be associated with severe lung involvement and increased readmission ratesEuropean Journal of Inflammation 2021; 19: 205873922110482 doi: 10.1177/20587392211048259
23
Claudio Barbiellini Amidei, Fabiana Zingone, Loris Zanier, Cristina Canova. Risk of Prevalent Asthma among Children Affected by Inflammatory Bowel Disease: A Population-Based Birth Cohort StudyInternational Journal of Environmental Research and Public Health 2020; 17(12): 4255 doi: 10.3390/ijerph17124255
24
Anna Cantarutti, Claudio Barbiellini Amidei, Camilla Valsecchi, Antonio Scamarcia, Giovanni Corrao, Dario Gregori, Carlo Giaquinto, Jonas Ludvigsson, Cristina Canova. Association of Treated and Untreated Gastroesophageal Reflux Disease in the First Year of Life with the Subsequent Development of AsthmaInternational Journal of Environmental Research and Public Health 2021; 18(18): 9633 doi: 10.3390/ijerph18189633
25
Pamela A. McCombe, Fleur C Garton, Matthew Katz, Naomi R Wray, Robert D Henderson. What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?Expert Review of Neurotherapeutics 2020; 20(9): 921 doi: 10.1080/14737175.2020.1785873
26
Manyu Li, Chaofan Zeng, Jiannan Yao, Yang Ge, Guangyu An. The association between proton pump inhibitors use and clinical outcome of patients receiving immune checkpoint inhibitors therapyInternational Immunopharmacology 2020; 88: 106972 doi: 10.1016/j.intimp.2020.106972
27
Youssef Bouferraa, Andrea Chedid, Ghid Amhaz, Ahmed El Lakkiss, Deborah Mukherji, Sally Temraz, Ali Shamseddine. The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and ChallengesInternational Journal of Molecular Sciences 2021; 22(15): 8036 doi: 10.3390/ijms22158036
28
Nadiya Hussain, Muntaha Naeem, David J. Pinato. Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?Human Vaccines & Immunotherapeutics 2021; 17(1): 55 doi: 10.1080/21645515.2020.1769398
29
Axel Dalhoff. Are antibacterial effects of non-antibiotic drugs random or purposeful because of a common evolutionary origin of bacterial and mammalian targets?Infection 2021; 49(4): 569 doi: 10.1007/s15010-020-01547-9
30
Sadia Tasnim, Aaron L. Miller, Daniel C. Jupiter, Catherine F. Hamilton, Gabriel L. Reep, Timothy S. Krill, Richard B. Pyles, Ikenna C. Okereke. Effects of proton pump inhibitor use on the esophageal microbial communityBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01460-3
31
Rodney R. Dietert. Microbiome First Medicine in Health and SafetyBiomedicines 2021; 9(9): 1099 doi: 10.3390/biomedicines9091099
32
Alessio Cortellini, Marco Tucci, Vincenzo Adamo, Luigia Stefania Stucci, Alessandro Russo, Enrica Teresa Tanda, Francesco Spagnolo, Francesca Rastelli, Renato Bisonni, Daniele Santini, Marco Russano, Cecilia Anesi, Raffaele Giusti, Marco Filetti, Paolo Marchetti, Andrea Botticelli, Alain Gelibter, Mario Alberto Occhipinti, Riccardo Marconcini, Maria Giuseppa Vitale, Linda Nicolardi, Rita Chiari, Claudia Bareggi, Olga Nigro, Alessandro Tuzi, Michele De Tursi, Nicola Petragnani, Laura Pala, Sergio Bracarda, Serena Macrini, Alessandro Inno, Federica Zoratto, Enzo Veltri, Barbara Di Cocco, Domenico Mallardo, Maria Grazia Vitale, David James Pinato, Giampiero Porzio, Corrado Ficorella, Paolo Antonio Ascierto. Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practiceJournal for ImmunoTherapy of Cancer 2020; 8(2): e001361 doi: 10.1136/jitc-2020-001361
33
Larissa Spósito, Giovanna Capaldi Fortunato, Bruna Almeida Furquim de Camargo, Matheus Aparecido dos Santos Ramos, Maurício Palmeira Chaves de Souza, Andréia Bagliotti Meneguin, Taís Maria Bauab, Marlus Chorilli. Exploiting drug delivery systems for oral route in the peptic ulcer disease treatmentJournal of Drug Targeting 2021; : 1 doi: 10.1080/1061186X.2021.1904249
34
Kiera Murphy, R. Paul Ross, C. Anthony Ryan, Eugene M. Dempsey, Catherine Stanton. Probiotics, Prebiotics, and Synbiotics for the Prevention of Necrotizing EnterocolitisFrontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.667188
35
Sofia D. Forssten, Arthur C. Ouwehand. Reference Module in Food Science2021;  doi: 10.1016/B978-0-12-819265-8.00059-0
36
Manon Cairat, Marie Al Rahmoun, Marc J. Gunter, Gianluca Severi, Laure Dossus, Agnès Fournier. Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal womenBreast Cancer Research 2020; 22(1) doi: 10.1186/s13058-020-01343-1
37
Cunye Yan, Yue Chen, Chenyu Sun, Mubashir Ayaz Ahmed, Chandur Bhan, Zhichun Guo, Hongru Yang, Yijing Zuo, Yue Yan, Lei Hu, Yiceng Sun, Yao Li, Qin Zhou. Will Proton Pump Inhibitors Lead to a Higher Risk of COVID-19 Infection and Progression to Severe Disease? A Meta-analysisJapanese Journal of Infectious Diseases 2021;  doi: 10.7883/yoken.JJID.2021.074
38
Andreas Thalheimer. Chirurgische Behandlung der RefluxkrankheitIm OP 2021; 11(03): 105 doi: 10.1055/a-1220-4293
39
Andrea Nuzzo, James R. Brown. The Microbiome Factor in Drug Discovery and DevelopmentChemical Research in Toxicology 2020; 33(1): 119 doi: 10.1021/acs.chemrestox.9b00333
40
Piotr Dziechciarz, Katarzyna Krenke, Hania Szajewska, Andrea Horvath. Lactobacillus rhamnosus GG Usage in the Prevention of Gastrointestinal and Respiratory Tract Infections in Children with Gastroesophageal Reflux Disease Treated with Proton Pump Inhibitors: A Randomized Double-Blinded Placebo-Controlled TrialPediatric Gastroenterology, Hepatology & Nutrition 2020; 23(3): 251 doi: 10.5223/pghn.2020.23.3.251
41
Yasutoshi Shiratori, Takashi Ikeya, Naoki Ishii, Kazuki Yamamoto, Tetsuro Honda, Kenkei Hasatani, Naohiro Yoshida, Tsutomu Nishida, Tetsuya Sumiyoshi, Shu Kiyotoki, Masahiro Arai, Ryota Niikura. Association between the chronic use of gastric acid suppressants and high‐risk colorectal polypsJGH Open 2021; 5(3): 371 doi: 10.1002/jgh3.12503
42
Mauro Giuffrè, Michele Campigotto, Giuseppina Campisciano, Manola Comar, Lory Saveria Crocè. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literatureAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(5): G889 doi: 10.1152/ajpgi.00161.2019
43
Fang Lu, Yurong Ma, Hui Huang, Yue Zhang, Hui Kong, Yan Zhao, Huihua Qu, Qingguo Wang, Yang Liu, Zhenhui Kang. Edible and highly biocompatible nanodots from natural plants for the treatment of stress gastric ulcersNanoscale 2021; 13(14): 6809 doi: 10.1039/D1NR01099A
44
Marzena Jabczyk, Justyna Nowak, Bartosz Hudzik, Barbara Zubelewicz-Szkodzińska. Microbiota and Its Impact on the Immune System in COVID-19—A Narrative ReviewJournal of Clinical Medicine 2021; 10(19): 4537 doi: 10.3390/jcm10194537
45
Nele Brusselaers, Omid Sadr-Azodi, Lars Engstrand. Long-term proton pump inhibitor usage and the association with pancreatic cancer in SwedenJournal of Gastroenterology 2020; 55(4): 453 doi: 10.1007/s00535-019-01652-z
46
Thiruvinvamalai S. Dharmarajan. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for DeprescribingJournal of the American Medical Directors Association 2021; 22(1): 15 doi: 10.1016/j.jamda.2020.09.046
47
Alexander J Friedman, Anna J Elseth, Joel R Brockmeyer. Proton Pump Inhibitors, Associated Complications, and Alternative Therapies: A Shifting Risk Benefit RatioThe American Surgeon 2021; : 000313482199198 doi: 10.1177/0003134821991988
48
Shingo Takashima, Fumio Tanaka, Yunosuke Kawaguchi, Yuki Usui, Kosuke Fujimoto, Yuji Nadatani, Koji Otani, Shuhei Hosomi, Yasuaki Nagami, Noriko Kamata, Koichi Taira, Tetsuya Tanigawa, Toshio Watanabe, Seiya Imoto, Satoshi Uematsu, Yasuhiro Fujiwara. Proton pump inhibitors enhance intestinal permeability via dysbiosis of gut microbiota under stressed conditions in miceNeurogastroenterology & Motility 2020; 32(7) doi: 10.1111/nmo.13841
49
Li-Qi Mao, Yan-Lin Zhou, Shuang-Shuang Wang, Lin Chen, Yue Hu, Lei-Min Yu, Jing-Ming Xu, Bin Lyu. Impact of Helicobacter pylori eradication on the gastric microbiomeGut Pathogens 2021; 13(1) doi: 10.1186/s13099-021-00460-2
50
Heidi Cecilie Villmones, Adrian Halland, Tore Stenstad, Elling Ulvestad, Harald Weedon-Fekjær, Øyvind Kommedal. The cultivable microbiota of the human distal ileumClinical Microbiology and Infection 2021; 27(6): 912.e7 doi: 10.1016/j.cmi.2020.08.021
51
Aws Hasan, Laith K. Hasan, Bernd Schnabl, Madeline Greytak, Rena Yadlapati. Microbiome of the Aerodigestive Tract in Health and Esophageal DiseaseDigestive Diseases and Sciences 2021; 66(1): 12 doi: 10.1007/s10620-020-06720-6